Close

Drug Research

Agilent and Tata Institute of Fundamental Research, Hyderabad collaborate...

In a significant step toward strengthening India’s efforts in nutrition and metabolism research, Agilent Technologies and the Tata Institute of Fundamental Research (TIFR), Hyderabad have...

Resistance-Evasive Antibiotic for Genes-Free Clinics

In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the...

Sarclisa by Sanofi has EC Approval to Treat Multiple...

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted...

Hengrui Pharma and GSK Ink Agreement on 12 Innovative...

In a recent move, Hengrui Pharma and GSK have inked an agreement when it comes to the development of almost 12 innovative medicines throughout several...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes...

AstraZeneca plans to invest $50 billion in America for...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...

UK government, Manufacturing, Investment, Clinical trials

The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy. In...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read